NASDAQ
Abivax S.A. (ABVX) has a free cash flow growth of -6.89% as of Friday, May 29, 2026. This represents a 83.22% increase compared to its 12-month average of -41.06%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.